ストックスクリーナーアプリを入手
7.56
3.06%
0.04
前日終値:
$7.52
開ける：
$7.29
24時間の取引高:
10,871
Relative Volume:
0.08
時価総額：
$8.94M
収益：
$3.50M
当期純損益:
$-37.33M
株価収益率:
-7.56
EPS:
-1
ネットキャッシュフロー:
$-19.15M
1週間 パフォーマンス:
-2.27%
1か月 パフォーマンス:
-35.42%
6か月 パフォーマンス:
-56.85%
1年 パフォーマンス:
-86.16%
1日の値動き範囲:
$7.2355
$7.8437
1週間の範囲:
$6.65
$8.42
52週間の値動き範囲:
$6.65
$100.80
Hcw Biologics Inc Stock (HCWB) Company Profile
HCWB を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
HCWB
Hcw Biologics Inc
|
7.75 | 8.94M | 3.50M | -37.33M | -19.15M | -1.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
506.27 | 126.09B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
590.94 | 64.01B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
645.89 | 36.63B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
261.64 | 30.64B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
259.62 | 27.24B | 3.81B | -644.79M | -669.77M | -6.24 |
Hcw Biologics Inc (HCWB) 最新ニュース
HCWB stock touches 52-week low at $6.99 amid sharp annual decline - Investing.com Australia
HCW Biologics (NASDAQ:HCWB) Trading 0.1% Higher – Here’s Why - Defense World
HCW Biologics faces lawsuit over construction contract breach - Investing.com Australia
HCW Biologics faces lawsuit over construction contract breach By Investing.com - Investing.com Canada
HCW Biologics enters key agreements; SEC non-review of filing By Investing.com - Investing.com South Africa
HCW Biologics enters key agreements; SEC non-review of filing - Investing.com
HCWB stock touches 52-week low at $8.04 amid market challenges By Investing.com - Investing.com South Africa
HCWB stock touches 52-week low at $8.04 amid market challenges - Investing.com Canada
HCWB stock touches 52-week low at $0.2 amid sharp annual decline By Investing.com - Investing.com South Africa
HCWB stock touches 52-week low at $0.2 amid sharp annual decline - Investing.com Australia
HCW Biologics Stock Set to Reverse Split on Friday, April 11th (NASDAQ:HCWB) - Defense World
HCW Biologics to Implement 1-for-40 Reverse Stock Split - MarketScreener
HCW Biologics approves reverse stock split to meet Nasdaq rules By Investing.com - Investing.com South Africa
HCW Biologics Announces 1-for-40 Reverse Stock Split - citybiz
HCW Biologics approves reverse stock split - Investing.com India
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
HCW Biologics Announces Reverse Stock Split Approval - TipRanks
HCW Biologics approves reverse stock split to meet Nasdaq rules - Investing.com
HCW Biologics approves 1-for-40 reverse stock split - TipRanks
HCW Biologics Announces 1-For-40 Reverse Stock Split - MarketScreener
HCW Biologics approves reverse stock split By Investing.com - Investing.com Canada
Major Stock Restructuring: HCW Biologics Announces 40:1 Reverse Split for Nasdaq Compliance - Stock Titan
Warner Bros Discovery Stock (NASDAQ:WBD) Slides as Film Boss Replacements Considered - The Globe and Mail
How major US stock indexes fared Tuesday, 4/1/2025 - The Globe and Mail
HCW BIOLOGICS Earnings Preview: Recent $HCWB Insider Trading, Hedge Fund Activity, and More - Nasdaq
HCW Biologics Reports Fourth Quarter and Fiscal Year 2024 Business Highlights and Financial Results - The Manila Times
HCW Biologics Inc. SEC 10-K Report - TradingView
HCW Biologics Secures FDA Green Light for Alopecia Treatment Despite $30M Annual Loss - Stock Titan
HCW Biologics amends agreement with WY Biotech amid delays - Investing.com
Stocks Attempt to Stabilize as Trump Set to Meet with Top US Executives - The Globe and Mail
HCW Biologics Granted Extension by the Nasdaq Hearings - GlobeNewswire
HCW Biologics Inc. Receives Extension from Nasdaq to Regain Compliance with Listing Rules - Nasdaq
Can HCW Biologics Meet Nasdaq's New June Deadline? Key Details Revealed - StockTitan
HCW Biologics Inc. announced that it expects to receive $20 million in funding -February 19, 2025 - Marketscreener.com
Zeta (ZETA) Q4 Earnings: What To Expect - The Globe and Mail
HCW Biologics Inc (HCWB) is looking forward to a strong quarter - SETE News
HCW Biologics Inc Inc. (HCWB) Price Performance: A Comparative Analysis with Competitors - The InvestChronicle
Navigating the Volatility of HCW Biologics Inc’s (HCWB) Stock - The News Heater
Trading Day Review: HCW Biologics Inc (HCWB) Loses Momentum, Closing at 0.43 - The Dwinnex
The Business Case For Buying HCW Biologics Inc (NASDAQ: HCWB) Stock Now - Stocks Register
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
HCW Biologics: Buy Rating Affirmed Amid IND Clearance and Strategic Advancements - TipRanks
HCW-9302 gains IND clearance for first-in-human study in alopecia areata - BioWorld Online
Why Palantir Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket - Benzinga
HCW Biologics Inc Inc. (HCWB) Price Performance: The Role of Share Buybacks and Stock Splits - The InvestChronicle
Penny Stocks To ResearchFebruary 03rd - MarketBeat
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Pharma company granted FDA clearance for alopecia drug study - The Business Journals
Hcw Biologics Inc (HCWB) 財務データ
収益
当期純利益
現金流量
EPS
1.91%
0.28%
大文字化:
|
ボリューム (24 時間):